-
Pfizer will complete the acquisition of Seagen and establish a new oncology department this week
Pfizer will complete the acquisition of Seagen and establish a new oncology department this week. Pfizer announced on December 12th local time that it is expected to complete the $43 billion acquisit ... -
Pfizer will complete the acquisition of Seagen and establish a new oncology department this week
Pfizer announced on December 12th local time that it is expected to complete a $43 billion acquisition of cancer pharmaceutical company Seagen later this week and plans to establish a new oncology de ... -
The "self-help" wisdom of China's first tumor NGS stock: Burning Stone Medical laid off 18.36% of employees and turned losses in business. Previously warned of delisting due to low stock price
Reported by Guo Yilin and Yu Na from Huaxia Times in Beijing Amidst a wave of questioning, the early screening track for cancer is struggling. After the delisting of Fanshengzi, the trading volume of ... -
因美纳：扩展TruSight Oncology产品线
南方财经11月20日电，因美纳公司（纳斯达克股票代码：ILMN）今日宣布，将推出其旗舰癌症研究检测产品的新版本TruSight Oncology 500 v2（TSO 500 v2），以实现基因组全景变异分析（CGP）。该检测目前正在开发中 ... -
Innolux: Expanding TruSight Oncology Product Line
On November 20th, Southern Finance and Economics reported that Innolux (NASDAQ: ILMN) announced today that it will launch a new version of its flagship cancer research detection product, TruSight Onc ...- lwh7654321
- 2024-11-20
- サポート
- に反対
- 返信
- コレクション
-
インメナ：TruSight Oncology製品ラインの拡張
南方財経は11月20日、ゲノムパノラマ変異分析（CGP）を実現するために、米納公司（ナスダック株式コード：ILMN）が旗艦がん研究測定製品の新バージョンTruSight Oncology 500 v 2（TSO 500 v 2）を発売すると発表し ... -
인메나: TruSight Oncology 제품 라인 확장
남방재경 11월 20일발 소식: 인미나회사 (나스닥주식코드: ILMN) 는 오늘 그 기함암연구검측제품의 새로운 버전인 TruSight Oncology 500 v2 (TSO 500 v2) 를 출시하여 게놈전경변이분석 (CGP) 을 실현한다고 선포 ...